CoChat

An investigator‐driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis

MALOUF, MONIQUE A., HOPKINS, PETER, SNELL, GREGORY, GLANVILLE, ALLAN R. · 2011 · Respirology
Cited by 100

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background and objective: We evaluated the efficacy and safety of everolimus, a macrocyclic proliferation signal inhibitor with anti‐fibroproliferative activity to prevent disease progression or death in patients with IPF, a progressive, fatal disease with no known effective therapy. Methods: Eighty‐nine patients with surgical lung biopsy confirmed IPF were enrolled in a 3‐year investigator‐driven, placebo‐controlled, double‐blinded, multicentre study of everolimus. Results: The everolimus (n = 44) and placebo (n = 45) groups were matched for demographic variables (gender, P = 0.46) and baseline lung function parameters (FVC, P = 0.29; TLC, P = 0.45; DL CO, P = 0.41 and PaO 2, P = 0.34). Independent risks for disease progression were everolimus (hazard ratio (HR) 2.37, 95% CI: 1.40–4.00, P < 0.01, log rank) and male gender (HR 2.76, 95% CI: 1.47–5.17, P < 0.01, log rank). Three‐year transplant‐free survival was 36 ± 7% (everolimus) versus 51 ± 8% (placebo) (Kaplan–Meier, P = 0.11, log rank). Independent risks for transplant‐free survival were male gender (HR 2.33, 95% CI: 1.07–5.05, P = 0.03, log rank) and baseline DL CO (% predicted) (HR 0.96, 95% CI: 0.93–0.99, P = 0.02, log rank). Conclusions: Everolimus use was associated with more rapid disease progression in a well‐defined cohort of patients with IPF confirmed by surgical lung biopsy followed for 3 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1843.2011.01955.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 100

Metadata

Authors
MALOUF, M. A., HOPKINS, P., SNELL, G., & GLANVILLE, A. R.
Venue
Respirology
Publisher
Wiley
Published
2011-06-28
Volume
16
Issue
5
Pages
776-783
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W2109920600
Cited by
100
References
7
FWCI
3.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An investigator‐driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1111/j.1440-1843.2011.01955.x
The paper
MALOUF, M. A., HOPKINS, P., SNELL, G., & GLANVILLE, A. R. (2011). An investigator‐driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis. Respirology. https://doi.org/10.1111/j.1440-1843.2011.01955.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.